KUBRA SERBEST CEYLANOGLU

Dr. KUBRA SERBEST CEYLANOGLU


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
EŞEmine Malkoç Şen
Emine Malkoç Şen
KCKUBRA SERBEST CEYLANOGLU
KUBRA SERBEST CEYLANOGLU
Trabekülektomi Sonrası Pitozis İnsidansını Etkileyen Faktörler

1 January 2023 in Arquivos Brasileiros de Oftalmologia
Verified
Journal Article
Open access
KCKUBRA SERBEST CEYLANOGLU
KUBRA SERBEST CEYLANOGLU
OKOnur Konuk
Onur Konuk
Purpose: To compare the radiologic and clinical features of primary lacrimal gland pleomorphic adenoma and adenoid cystic carcinoma. Methods: This study retrospectively reviewed imaging findings and medical records of lacrimal gland pleomorphic adenoma and adenoid cystic carcinoma. Results: Eleven patients with pleomorphic adenoma and 16 patients with adenoid cystic carcinoma were evaluated. There were no statistically significant differences between groups regarding age or sex. Proptosis was the most common presenting symptom in both groups. Adenoid cystic carcinomas were more likely to present with a palpable mass, diplopia, pain, and sensory loss than pleomorphic adenomas, although the differences were not statistically significant between groups. Furthermore, there were no significant differences in terms of homogeneity and globe indentation between lacrimal gland pleomorphic adenoma and adenoid cystic carcinoma on computed tomography (CT)(all p>0.05). The rates of bone invasion, tumor calcification, and wedge sign were significantly higher in adenoid cystic carcinomas, and bone remodeling was statistically significantly higher in pleomorphic adenomas, on CT(all p<0.05). Pleomorphic adenomas were significantly more likely to show well-defined margins, lobulated contours, heterogeneous contrast enhancement, and hyperintensity on T2-weighted magnetic resonance images (all p<0.05). Conclusion: When differentiating between lacrimal gland pleomorphic adenoma and adenoid cystic carcinoma, evaluation of radiologic features along with clinical features is of great importance. Lobulated contours may be a significant distinguishing radiologic feature suggesting pleomorphic adenoma.

1 April 2022 in Clinical and Experimental Optometry
Verified
Journal Article
Closed access
KCKUBRA SERBEST CEYLANOGLU
KUBRA SERBEST CEYLANOGLU
ESEmine Malkoc Sen
Emine Malkoc Sen
MSMehmet Ali Sekeroglu
Mehmet Ali Sekeroglu
Pupillary characteristics may be affected in patients with Graves’ ophthalmopathy (GO). However, small changes cannot be observed with clinical examination. Ophthalmologists and optometrists should...

9 July 2022 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
KCKUBRA SERBEST CEYLANOGLU
KUBRA SERBEST CEYLANOGLU
NENazan Acar Eser
Nazan Acar Eser
ESEmine Malkoc Sen
Emine Malkoc Sen

1 June 2023 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
EBEmine Gökçen Bayuk
Emine Gökçen Bayuk
EŞEmine Malkoç Şen
Emine Malkoç Şen
FEFatma Çorak Eroğlu
Fatma Çorak Eroğlu
KCKUBRA SERBEST CEYLANOGLU
KUBRA SERBEST CEYLANOGLU
EEEbru Evren
Ebru Evren
Primer Kanalikülitli Hastaların Uzun Dönem Takip Sonuçları

2 January 2024 in Cornea
Verified
Journal Article
Closed access
KCKUBRA SERBEST CEYLANOGLU
KUBRA SERBEST CEYLANOGLU
AEAnne Bsba Eisenberg
Anne Bsba Eisenberg
FWFrancis Paul Worden
Francis Paul Worden
VEVictor Mauris Elner
Victor Mauris Elner
HDHakan Demirci
Hakan Demirci
Purpose: Immune checkpoint inhibitors (ICIs) have been recently introduced for the treatment of locally unresectable conjunctival squamous cell carcinoma. We present 2 cases with conjunctival intraepithelial neoplasia (CIN) who were treated with ICIs. Methods: A report of 2 cases with CIN who were treated with systemic cemiplimab (350 mg IV every 3 weeks). Results: A 70-year-old man was treated with cemiplimab for metastatic cutaneous squamous cell carcinoma. The pre-existing CIN continued to progress over the nasal bulbar conjunctiva and cornea, while the other metastatic sites, including parotid glands, and neck lymph nodes showed a complete response after 16 cycles of treatment. An 84-year-old woman had bilateral diffuse CIN involving bulbar and lower eyelid palpebral conjunctiva. Cemiplimab was started because of the extent of involvement. While the bulk of CIN was reduced, it progressed over the cornea and forniceal conjunctiva on OU after 10 cycles of treatment. Excisional biopsies of conjunctival lesions after cemiplimab confirmed CIN in both patients. Conclusions: Although conjunctival squamous cell carcinoma tumors are reported to be highly responsive to ICIs, a similar effect has not been observed in 2 patients with CIN. Further studies are needed to evaluate ICIs in the management of CIN.